The Effect of 40gr Okara on Gastric Emptying
NCT01079585 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2010-03-03
Summary
The effect of 40gr Okara, on gastric emptying of standard meal (Muffin cake)
Conditions
- Healthy People
Interventions
- DIETARY_SUPPLEMENT
-
Nutrigal Okara - 100
Sponsors & Collaborators
-
Nutrigal LTD
collaborator UNKNOWN -
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2010-10-31
- Completion
- 2010-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Gastric Emptying and Gallbladder Motility Study
NCT00940849 ·Status: COMPLETED ·Phase: NA
-
Repetitive Brake Activation
NCT02511366 ·Status: COMPLETED ·Phase: NA
-
The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty Liver
NCT01956825 ·Status: UNKNOWN ·Phase: PHASE4
-
Weight-Adjusted Dosing of 3-OHB in Patients With Chronic Heart Failure
NCT04594265 ·Status: UNKNOWN ·Phase: PHASE2
-
Lactate in the Gut
NCT04299815 ·Status: COMPLETED ·Phase: NA
-
The Effect of Physical Properties of Lipid Emulsions on Gastrointestinal Function
NCT01253005 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
NCT02187094 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
CLEANS Technique for the Treatment of Esophageal Food Impaction
NCT03570567 ·Status: UNKNOWN ·Phase: NA
-
Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure
NCT04604275 ·Status: TERMINATED ·Phase: PHASE2
-
Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF
NCT04238416 ·Status: COMPLETED ·Phase: PHASE1
-
Slowly Digestible Carbohydrates and the Ileal Brake
NCT03630445 ·Status: COMPLETED ·Phase: NA
-
Malnutrition in Chronic Pancreatitis, Trans-sectoral Study
NCT04476056 ·Status: UNKNOWN ·Phase: NA
-
Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis
NCT03855956 ·Status: COMPLETED ·Phase: NA
-
Metabolic Changes Associated With Weight Gain After Treatment of Achalasia
NCT07334639 ·Status: NOT_YET_RECRUITING
-
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
NCT04227678 ·Status: RECRUITING ·Phase: NA
-
Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects
NCT01002261 ·Status: COMPLETED
-
REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID
NCT05840237 ·Status: COMPLETED ·Phase: NA
-
L-carnitine Corrects Ammonia Metabolism in Hepatectomized Patients
NCT03021876 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)
NCT03477903 ·Status: TERMINATED ·Phase: PHASE2
-
Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency
NCT00095732 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
NCT00004315 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
NCT00006061 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effects Associated With the Administration of Akkermansia Muciniphila on Parameters of Metabolic Syndrome
NCT02637115 ·Status: COMPLETED ·Phase: NA
-
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
NCT06910943 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
ButyraGen™, Short Chain Fatty Acids and Gut Microbiome
NCT05601635 ·Status: COMPLETED ·Phase: NA